跳至主要内容
临床试验/NCT01940614
NCT01940614已完成不适用

Use of Copeptin in the Differential Diagnosis of Diabetes insipidus-a Prospective International Study

University Hospital, Basel, Switzerland1 个研究点 分布在 1 个国家目标入组 156 人开始时间: 2013年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
156
试验地点
1
主要终点
Overall diagnostic accuracy

研究概览

简要总结

Prospective evaluation of the novel biomarker copeptin in the differential diagnosis of diabetes insipidus against the standard diagnostic test methods.

详细描述

Purpose of this study is to compare the overall diagnostic accuracy of the three following diagnostic test procedures in diabetes insipidus (central, nephrogenic) and primary polydipsia: a) classical water deprivation test alone, b) classical water deprivation test plus plasma copeptin cut-off levels, c) hypertonic saline infusion test plus plasma copeptin measurement.

The investigators hypothesize that firstly b) and c) is better as a). Secondly the investigators hypothesize that c) is non-inferior to b).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
16 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Polyuria or/and Polydipsia or/and therapy with synthetic adenovirus proteinase (AVP) derivate
  • Urine osmolality <800mOsm/kgH20

排除标准

  • Polyuria due to diabetes mellitus
  • Hypokalemia
  • Hyperkalemia (>5mmol/l)
  • Hypercalcemia
  • Kidney disease (min.: glomerular filtration rate (GFR) 60ml/min/1.73m2)
  • Pregnancy
  • Hyponatremia >135mmol/L
  • Hypernatremia >145mmol/L
  • Hypo- or hypervolemia
  • uncorrected adrenal or thyroidal deficiency
  • Cardia failure
  • Epilepsia
  • Uncontrolled hypertension

结局指标

主要结局

Overall diagnostic accuracy

时间窗: beginning and end of protocol, up to 9hours

Ratio of the number of correctly diagnosed patients to the number of all tested patients for the tests: * classical water deprivation test alone * classical water deprivation test plus plasma copeptin cut-off levels * hypertonic saline Infusion test plus plasma copeptin measurements

次要结局

  • Sensitivity, specificity, positive and negative predictive value(beginning and end of protocol, up to 9hours)
  • post-hoc best copeptin cut-off optimising overall performance(beginning and end of protocol, up to 9hours)
  • subjective burden as rated by patients on visual analogue scale(beginning, during and end of protocol, up to 9hours)
  • Predictive value of specific anamnestic and clinical features(before tests)
  • Predictive value of absent bright spot in posterior pituitary enlargement(before or after tests)

研究者

发起方
University Hospital, Basel, Switzerland
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验